Advances in Radiation Therapy for Malignant Pleural Mesothelioma

Cramer, Gwendolyn M.; Simone, Charles B.; Busch, Theresa M.; Cengel, Keith A.

doi:10.1007/174_2022_333

Medical Radiology

2023

DOI: 10.1007/174_2022_333

|View full text |Cite

Advances in Radiation Therapy for Malignant Pleural Mesothelioma

Gwendolyn M. Cramer

Charles B. Simone

Theresa M. Busch

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 61 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

The role of radiotherapy in the treatment of malignant pleural mesothelioma - possibilities and controversy

Arsenijevic,

Stepanovic,

Nikitovic

2024

Srp Arh Celok Lek

View full text Add to dashboard Cite

Malignant pleural mesothelioma (MPM) is a rare malignancy with a poor prognosis. In recent years, significant progress has been made in the treatment of this disease, including surgical and radiotherapy techniques, systemic and immunotherapy. Due to the wide range of clinical presentations, lack of phase III randomized trials, and heterogeneity in treatment approach, the treatment of malignant pleural mesothelioma remains challenging regardless of available diagnostic and therapeutic guidelines. The limited possibility to avoid critical healthy organs (particularly lungs) which can lead to severe, and even fatal radiation-induced toxicity, makes high-dose radical radiotherapy very demanding. Thus, the majority of patients in the era of conventional radiotherapy were mostly referred to no more than palliative radiotherapy only. Technological development in radiotherapy such as respiratory gating, 4D computed tomography (4DCT), intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT), stereotactic techniques, and proton therapy, made a step forward in treating malignant pleural mesothelioma with this modality. Today, MPM radiotherapy can be considered in various indications, alone or in combination with surgery and systemic treatment. However, many questions remain open, and further investigation is needed especially in dose escalation possibility and lung sparing.

show abstract

The role of radiotherapy in the treatment of malignant pleural mesothelioma - possibilities and controversy

Arsenijevic,

Stepanovic,

Nikitovic

2024

Srp Arh Celok Lek

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Advances in Radiation Therapy for Malignant Pleural Mesothelioma

Cited by 1 publication

References 61 publications

The role of radiotherapy in the treatment of malignant pleural mesothelioma - possibilities and controversy

The role of radiotherapy in the treatment of malignant pleural mesothelioma - possibilities and controversy

Contact Info

Product

Resources

About